GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stryker Corp (NYSE:SYK) » Definitions » Cash Conversion Cycle
中文

Stryker (Stryker) Cash Conversion Cycle : 204.58 (As of Dec. 2023)


View and export this data going back to 1988. Start your Free Trial

What is Stryker Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Stryker's Days Sales Outstanding for the three months ended in Dec. 2023 was 55.24.
Stryker's Days Inventory for the three months ended in Dec. 2023 was 210.11.
Stryker's Days Payable for the three months ended in Dec. 2023 was 60.77.
Therefore, Stryker's Cash Conversion Cycle (CCC) for the three months ended in Dec. 2023 was 204.58.


Stryker Cash Conversion Cycle Historical Data

The historical data trend for Stryker's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stryker Cash Conversion Cycle Chart

Stryker Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 226.38 243.13 205.78 191.77 210.18

Stryker Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 180.36 208.42 215.85 239.35 204.58

Competitive Comparison of Stryker's Cash Conversion Cycle

For the Medical Devices subindustry, Stryker's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stryker's Cash Conversion Cycle Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stryker's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Stryker's Cash Conversion Cycle falls into.



Stryker Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Stryker's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=65.26+216.79-71.87
=210.18

Stryker's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=55.24+210.11-60.77
=204.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stryker  (NYSE:SYK) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Stryker Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Stryker's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Stryker (Stryker) Business Description

Address
2825 Airview Boulevard, Kalamazoo, MI, USA, 49002
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
Executives
Srikant Datar director ICF INTERNATIONAL, INC., 9300 LEE HIGHWAY, FAIRFAX VA 22031
Berry William E Jr officer: Vice President, Controller 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Kevin Lobo officer: Group Pres., Neurotech & Spine STRYKER, 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Viju Menon officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Allan C. Golston director 2825 AIRVIEW BLVD., KALAMAZOO MI 49002
Ronda E Stryker director 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Robert S Fletcher officer: VP, Chief Legal Officer 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
James Andrew Pierce officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Glenn S Boehnlein officer: Vice President, CFO 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
M Kathryn Fink officer: VP, Global Human Resources 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Spencer S Stiles officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Giovanni Caforio director BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 & PROVINCELINE ROAD, LAWRENCEVILLE NJ 08543
Timothy J Scannell officer: Group President 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Roch Doliveux director 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Katherine Ann Owen officer: VP 2825 AIRVIEW BLVD., KALAMAZOO MI 49002

Stryker (Stryker) Headlines

From GuruFocus

Q1 2023 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q4 2020 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Stryker Corp To Host Investor Day Transcript

By GuruFocus Research 01-23-2024

Q1 2021 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024